REQUEST A DEMO
Total
USD $0.00
Search more companies

Doropharm, k.s. (Slovakia)

Main Activities: Management, Scientific, and Technical Consulting Services
Full name: Doropharm, k.s. Profile Updated: April 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Doropharm, k.s. is a company in Slovakia, with a head office in Bratislava. The company operates in the Management, Scientific, and Technical Consulting Services industry. The company was established on October 25, 2007. Doropharm, k.s. currently employs 20 - 24 (2023) people. From the latest financial highlights, Doropharm, k.s. reported a net sales revenue increase of 30.19% in 2022. Over the same period, its total assets grew by 25.67%. In 2022, Doropharm, k.s.’s net profit margin increased by 0.57%.

Headquarters
Stara Vajnorska 21
Bratislava; Bratislavsky; Postal Code: 83104

Contact Details: Purchase the Doropharm, k.s. report to view the information.

Website: http://www.doropharm.sk

Basic Information
Total Employees:
Purchase the Doropharm, k.s. report to view the information.
Outstanding Shares:
Purchase the Doropharm, k.s. report to view the information.
Registered Capital:
Purchase the Doropharm, k.s. report to view the information.
Incorporation Date:
October 25, 2007
Key Executives
Company Performance
Financial values in the chart are available after Doropharm, k.s. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
30.19%
Total operating revenue
30.43%
Operating profit (EBIT)
61.82%
EBITDA
58.77%
Net Profit (Loss) for the Period
66.37%
Total assets
25.67%
Total equity
27.61%
Operating Profit Margin (ROS)
0.65%
Net Profit Margin
0.57%
Return on Equity (ROE)
6.82%
Debt to Equity Ratio
0%
Quick Ratio
0.18%
Cash Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?